{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Roswell Park Comprehensive Cancer Center"
  ],
  "article_type": "New results",
  "arxiv": null,
  "author_total": 23,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "G. M. Das"
    },
    {
      "name": "C. C. Oturkar"
    },
    {
      "name": "J. H. Park"
    },
    {
      "name": "C. Adams"
    },
    {
      "name": "I. Ijaz"
    },
    {
      "name": "M. Oshi"
    },
    {
      "name": "M. Dolan"
    },
    {
      "name": "A. Caradori"
    },
    {
      "name": "Y. Zhang"
    },
    {
      "name": "J. Wang"
    },
    {
      "name": "B. Boleslav"
    },
    {
      "name": "D. Mager"
    },
    {
      "name": "A. Nair"
    },
    {
      "name": "T. Samanta"
    },
    {
      "name": "K. H. Jung"
    },
    {
      "name": "S. Y. Han"
    },
    {
      "name": "S. Yang"
    },
    {
      "name": "A. Tiwari"
    },
    {
      "name": "R. Mishra"
    },
    {
      "name": "J. Ebos"
    },
    {
      "name": "K. Attwood"
    },
    {
      "name": "K. Takabe"
    },
    {
      "name": "B. A. Kaipparettu"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/9vf1m71jv6885.bib",
  "cited_by": 0,
  "doi": "10.64898/2026.10.21.760572",
  "fulltext_url": "https://www.biorxiv.org/content/10.64898/2026.10.21.760572v1.full",
  "id": "9vf1m71jv6885",
  "issns": [],
  "landing_url": "https://www.biorxiv.org/content/10.64898/2026.10.21.760572v1",
  "language": null,
  "licence": "LicenseRef-all-rights-reserved",
  "licence_label": "All rights reserved",
  "licence_source": "article",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "biorxiv",
      "cancer biology"
    ],
    [
      "openalex",
      "2730|Cancer-related Molecular Pathways"
    ]
  ],
  "openalex": "W7223287480",
  "pdf_url": "https://www.biorxiv.org/content/10.64898/2026.10.21.760572v1.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-21",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/9vf1m71jv6885.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:29:19Z",
      "native_id": "10.64898/2026.10.21.760572",
      "source": "biorxiv",
      "url": "https://www.biorxiv.org/content/10.64898/2026.10.21.760572v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "biorxiv:cancer biology",
      "subfield": "oncology"
    }
  ],
  "title": "Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer",
  "title_text": "Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer",
  "type": "preprint",
  "updated_at": "2026-10-30T12:29:19Z",
  "url": "https://research.draconitic.com/paper/9vf1m71jv6885",
  "venue": "bioRxiv",
  "versions": []
}